Clinical trial
A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of the Medication Tracking and Educational Components of a Clinical Learning Version of CT-155 in People With Schizophrenia
NCT05438160 is registered in ClinicalTrials.gov with Click Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of the Medication Tracking and Educational Components of a Clinical Learning Version of CT-155 in People With Schizophrenia
- Lead sponsor
- Click Therapeutics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2022
- Completion date
- July 31, 2022
- Enrollment
- 48 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.